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Abstract 
Lysine-vasopressin, a nonapeptide, was synthesised on a benzhydryl-resin using 
solid-phase peptide synthesis via the Boc-strategy. The benzyl group was used in the 
protection of the side-chains of tyrosine and cysteine, while 1-tetralinyl, benzhydryl 
and benzyloxycarbonyl groups were used in the protection of the side-chains of 
asparagine, glutamine and lysine, respectively. Thioanisole–1,2-ethanedithiol–
trifluoroacetic acid–trifluoromethanesulphonic acid (2:1:20:2 v/v) was used to cleave 
the peptide-resin under different temperature conditions. The cleavage at 40 °C for 
two hours gave lysine-vasopressin in a one-pot reaction; the yield after reversed-
phase HPLC purification was 62%. 
 
Keywords solid-phase peptide synthesis; cyclic peptide; electrospray mass 
spectrum; benzhydryl-resin; 1-tetralinyl, amide protection. 
 
1. Introduction 
Lysine-vasopressin is a hormone of the mammalian neurohypophysis.1 This hormone 
is responsible for pressor and diuretic effects. It exerts a marked effect on the 
kidneys, accelerating the rate of water reabsorption. This leads to the excretion of 
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urine, which contains increased concentrations of sodium and chloride ions, total 
nitrogen and phosphates. Its secretion is augmented in circumstances of dehydration 
and increased salt intake. This nonapeptide hormone was first synthesised in 
solution using the classical methods of peptide chemistry.2 Its synthesis has been 
made more efficient with the development of solid-phase peptide synthetic methods 
(SPPS).3,4 
 Side-chain amide protection of asparagine (Asn) or glutamine (Gln) has been 
considered optional.5 These amide side-chains are liable to undergo dehydration 
during the coupling steps.6–8 This side reaction does not occur when active esters are 
used.5,6,8–10 Several carboxamide-protecting groups such as 2,4,6-trimeth-
oxybenzyl,11,12 4,4’-dimethoxybenzhydryl,13 triphenylmethyl,14 4-methyltrityl,15 
2,4-dimethoxybenzyl11,12,16 and 1-tetralinyl17,18 have been developed in order to 
reduce or eliminate the aforementioned side reaction during peptide 
synthesis. In this project, we were encouraged to examine whether 
the 1-tetralinyl group (see insert) is viable as an asparagine amide-
protecting group in the solid-phase peptide synthesis of lysine-
vasopressin. 
 The most popular cleavage reagent for tert-butoxycarbonyl (Boc)-based 
peptide resins is anhydrous hydrogen fluoride. Whereas it is least harmful to a 
variety of peptides, its major drawback is its high toxicity and reactivity. The use of 
trifluoromethanesulphonic acid (TFMSA)19–21 as an alternative to hydrogen fluoride 
cleavage has been encountered in the literature. This cleavage reagent is capable 
of removing most protecting groups at room temperature. Other stable groups can 
be removed at a slightly elevated temperature (40 °C). 
 Disulphide bonds in peptides are important for the maintenance of biological 
activity and conformational stability. These bonds in peptides are usually formed after 
the linear peptide has been synthesised, the side-chain-protecting groups removed, 
and the peptide detached from the resin.22 This procedure is quite time-consuming. A 
one-pot synthesis has been developed for disulphide-containing bonds, which 
simultaneously cleaves, deprotects and oxidizes the cysteines.23 Thus, cystine-
containing peptides have been obtained after treatment of the protected peptidyl 
resin with trifluoroacetic acid (TFA) in the presence of iodine.23 Other oxidants 




Protected amino acid derivatives and benzhydrylamine hydrochloride salt resin 
(loading: 0.9 mmol g–1) were obtained from Sigma (St. Louis, USA). TFA, TFMSA, 
thioanisole and 1,2-ethanedithiol (EDT) were obtained from Fluka (Buchs, 
Switzerland). All solvents were of analytical grade or of equivalent purity, and were 
used without further purification. Dichloromethane, methanol, ethanol and 
N,N-dimethylformamide were purchased from BDH Chemicals Ltd (Poole, England). 
 Peptide chain assemblies by Boc-chemistry were carried out manually. Side-
chain protection was provided by benzyl for cysteine and tyrosine; benzyloxycarbonyl 
for lysine; benzhydryl for glutamine and 1-tetralinyl for asparagine. Boc removal was 
achieved with TFA–CH2Cl2–anisole (50:48:2 v/v) for 25 min at room temperature. 
Final release of peptide from the support and concomitant cleavage of side-chain 
protecting groups was achieved with thioanisole–EDT–TFA–TFMSA (2:1:20:2 v/v). 
Peptide couplings were monitored using ninhydrin. 
 IR (cm–1) spectra were recorded on a Perkin Elmer 1600 series (FTIR). Ion 
Electrospray Mass Spectra were determined on a Sciex API III TAGA 6000 (Toronto, 
Canada). ES–MS samples were prepared by dissolving 1 mg of peptide in 1 mL of 
5% acetic acid (AcOH), MeCN or MeOH–H2O (80:20 v/v). Analytical high-
performance liquid chromatography (HPLC) of crude peptide was performed using a 
Grom analytical nucleosil C-18 reversed-phase column (5 µm, 250 ×  2 mm) on a 
Beckman system, configured with a Programmable Solvent Module 126 with Auto 
Sampler 507 and a variable wavelength Diode Array Detector Module 168. This was 
controlled from a computer with Beckman System Gold Software. Peptide samples 
(1 mg mL-1 of MeOH) were chromatographed at 0.3 mL min–1 using a linear gradient 
of 0.1% aqueous TFA and 0.1% TFA in MeCN (10:90 to 0:100 over 45 min), 
detection at 214 and 280 nm. Semi-preparative HPLC was performed using a Grom 
semi-preparative nucleosil C-18 reversed-phase column (7 µm, 250 × 8 mm) on a 
Waters 600 Multi Solvent Delivery System (Milford, Massachusetts, USA) using 
manual injection (0.5 mL, 5 mg of peptide per run) and elution at 3.5 mL min–1 using 
0.1% aqueous TFA and 0.1% TFA in MeCN (90:10 to 30:70 over 45 min), detection 
at 214 nm. 
 Amino acid analysis was done using Applied Biosystems Model 420A 
Derivatizer 8 coupled to an Applied Biosystems Model 130A Micro Separation 
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System (Foster City, California, USA). Peptide (1–2 nmol) was dissolved in 10 µL of 
MeOH or MeCN-H2O (1:1 v/v). Hydrolysis was done using aq. HCl (6 mol L–1) at 
170 °C for 3 h. Sequencing of amino acids was performed using Applied Biosystems 
Model 476A and 477A (Foster City, California, USA). Samples were prepared by 
dissolving peptide (ca. 1 pmol) in MeOH (15 µL). 
 
Synthesis of Glycinamide Resin 
In a 60 mL solid-phase reaction vessel, the benzhydrylamine hydrochloride salt resin 
(5 g) was washed three times each with aq. Na2CO3 solution (10%), H2O–dioxane 
(3:1 v/v), MeOH and CH2Cl2. The resin was then suspended in CH2Cl2 (35 mL) and 
shaken for 10 min. After removal of the solvent, the resin was treated with Boc-
glycine (1.82 g, 10.4 mmol) in CH2Cl2 (8 mL) and N,N-dicyclohexylcarbodiimide 
(DCC) (2.14 g, 10.4 mmol) in the same solvent (18 mL) for 20 min at room 
temperature. After several washes with CH2Cl2 and EtOH, the coupling procedure 
was repeated twice more for 60 min each with half the quantities of Boc-glycine and 
DCC in the same volume of CH2Cl2. The resin was then washed sequentially with 
CH2Cl2, EtOH and CH2Cl2 (3 ×  35 mL each), and the unreacted amino groups were 
blocked by treatment with N-acetylimidazole (8 g, 72 mmol) in CH2Cl2 (60 mL) for 2 h 
at 23 °C. The ninhydrin test for the presence of free amino groups indicated that 
there were no exposed amino groups. The weight of the resin was 5.408 g. The 




Resin (Lysine-vasopressin resin, R3) 
The glycinamide resin (2 g) was utilized for the preparation of this compound. The 
following cycles of deprotection, neutralization and coupling were carried out for the 
introduction of each new residue in the peptide: (1) washing with CH2Cl2 (3 ×  18 mL); 
(2) cleavage of the Boc group by treating with TFA–CH2Cl2–anisole (50:48:2 v/v; 
18 mL) for 25 min at room temperature; (3) washing with CH2Cl2 (5 ×  18 mL); 
(4) washing with CHCl3 (4 ×  18 mL); (5) neutralization with triethylamine in CHCl3 
(7:93 v/v; 2 ×  15 mL) for 6 min at room temperature; (6) washing with CHCl3 (3 ×  
18 mL); (7) washing with CH2Cl2 (4 ×  18 mL); (8) addition of appropriate Boc-amino 
acid (2 mmol) in CH2Cl2 (9 mL) and 5 min of mixing; (9) addition of DCC 
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(0.41 g, 2 mmol) in CH2Cl2 (9 mL) followed by a reaction period of 90 min at room 
temperature; (10) washing with CH2Cl2 (3 ×  18 mL); (11) washing with EtOH (3 ×  
18 mL); (12) washing with CH2Cl2 (3 ×  18 mL); (13) repetition of steps 8 and 9 but 
using Boc-amino acid (1 mmol) and DCC (1 mmol), respectively; (14) washing with 
CH2Cl2 (3 ×  18 mL); (15) washing with EtOH (3 ×  18 mL). Unless otherwise 
specified, each washing and mixing step lasted for 2 min. The ninhydrin test was run 
to monitor the coupling steps (sample was run just before step 2). Yield: 3.22 g (89%, 
based on the glycinamide substitution on the resin); νmax/cm–1 (KBr) 3297 (N–H), 
1678 (broad, C=O). 
 
Lysine-vasopressin Resin Cleavage at Room Temperature for Two Hours (P3) 
To the dried resin (250 mg) was added thioanisole–EDT (2:1 v/v; 750 µL). TFA 
(5 mL) was then added and the mixture was stirred at room temperature for about 
10 min. TFMSA (500 µL) was then added slowly to the chilled mixture with vigorous 
stirring to dissipate the heat generated. Stirring was continued at room temperature 
for 2 h. The mixture was then filtered using a sintered glass funnel and the peptide 
was precipitated by adding Et2O (60 mL). The solvent was decanted and the 
procedure was repeated twice. TFA (5 mL) was then added to dissolve the peptide, 
followed by Et2O (60 mL) for re-precipitation, and decanting of the supernatant 
solvent. This was repeated five more times for the complete removal of the 
scavengers. The product was then dried under vacuum to give crude peptide P3 
(42 mg, 60%); νmax/cm–1 (KBr) 3296 (N–H), 3086.1 (Ar–H), 1667.9 (C=O);  
ES-MS m/z 1239 (21.3%) (calcd for C60H80N13O12S2, M+, 1239.5), 1369 (17%) (calcd 
for C70H90N13O12S2, M+, 1369.7), 1406 (40.4%) (calcd for C73H90N13O12S2, 
M+, 1405.7), 1536 (25.5%) (calcd for C83H100N13O12S2, M+, 1535.9). 
 
Lysine-vasopressin Cleavage at 40 °C for Half an Hour (PP3) 
The resin was cleaved as done in the preparation of P3, but the cleavage was done 
at 40 °C for 30 min to give crude peptide PP3 (63.12 mg, 90%); νmax/cm–1 
(KBr) 3318 (N–H), 3096.6 (Ar–H), 1662.6 (C=O); ES-MS m/z 1239 (10%) (calcd for 
C60H80N13O12S2, M+, 1239.5), 1406 (18.5%), (calcd for C73H90N13O12S2, M+, 1405.7). 
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Lysine-vasopressin Cleavage at 40 °C for Two Hours (PPP3) 
The resin was cleaved as done in the preparation of P3, but the cleavage was done 
at 40 °C for 2 h to give crude peptide PPP3 (66.31 mg, 94.6%); νmax/cm–1 (KBr) 
3360.2 (N–H), 3096.6 (Ar–H), 1683.7 (C=O); ES-MS m/z 1056.5 (100%) (calcd for 
C46H66N13O12S2, M+, 1057.2), 1148.5 (44.6%) (calcd for C53H73N13O12S2, M+, 1148.4), 
1239 (17.7%) (calcd for C60H80N13O12S2, M+, 1239.5). Amino acid analysis: Asp 
1.17 (1); Glu 0.88 (1); Gly 1.12 (1); Pro 1.00 (1); Tyr 0.39 (1); Cys 1.82 (2); Phe 
0.82 (1); Lys 0.85 (1); Sequence analysis: order of amino acid residues was Tyr, 
Phe, Gln, Asn, Pro, Lys and Gly (residues 1 and 6 were not determined owing to 
formation of cystine derivative); Analytical HPLC gave major peaks with retention 
times (min) of 12.30 (m/z 1056.5), 16.24 (m/z 1148) and 27.91. Detection was at 
214 nm. Crude peptide (10 mg) was used in the separation of the pure peptide by 
semi-preparative HPLC. Fraction 1 with the correct peptide was pooled and 
lyophilized to give a white powder (6.2 mg, 5.8 µmol, 62% isolated yield). 
 
3. Results and Discussion 
3.1. Lysine-vasopressin Resin (R3) 
The nonapeptide was synthesised by SPPS via the Boc-strategy from 2 g of Boc-
glycinamide resin. Cys and Tyr side-chains were protected with benzyl (Bn) groups. 
Side-chains of Gln, Asn and Lys were protected with benzhydryl (Bzh), 1-tetralinyl 
(Tet) and benzyloxycarbonyl (Cbz) groups respectively. The weight of the resin after 
the synthesis was 3.22 g (89%, based on the first amino acid anchored on the resin). 
During the incorporation of the first amino acid on the resin, it loses water to give a 
residue whose molecular mass (MM) is less by 18. In the subsequent coupling of the 
other amino acids, there will be loss of Boc (MM 101) and OH (MM 17) to give a 
residue that has molecular mass that is less by 118 (Table 1). No peak due to the 
cyano functional group was seen in the IR spectrum. 
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Gly 175.17 157.15 0.1509 2.0000 0.480 
Lys 380.42 262.42 0.2519 2.2519 0.426 
Pro 215.23   97.23 0.0933 2.3452 0.409 
Cys 311.36 193.36 0.1856 2.5308 0.379 
Asn 362.43 244.43 0.2347 2.7655 0.347 
Gln 412.49 294.49 0.2827 3.0482 0.315 
Phe 265.29 147.29 0.1414 3.1896 0.301 
Tyr 371.39 253.39 0.2433 3.4329 0.280 
Cys 311.36 193.36 0.1856 3.6185 0.265 
 
3.2. Lysine-vasopressin Resin Cleavage at Room Temperature for Two Hours 
(P3) 
Under the cleavage conditions with thioanisole–EDT–TFA–TFMSA as described in 
the experimental section, the benzyl group used in the protection of cysteine was not 
removed, while 1-tetralinyl (for asparagine protection) and benzhydryl (for glutamine 
protection), were partially cleaved. No cyclic lysine-vasopressin was formed. 
 
3.3. Lysine-vasopressin Cleavage at 40 °C for Half an Hour (PP3) 
Under this cleavage condition, benzyl (cysteine protection) was not removed at all, 
while benzhydryl (glutamine protection) was partially removed. The 1-tetralinyl 
(asparagine protection) group, on the other hand, was completely removed. No cyclic 
lysine-vasopressin was formed. 
 
3.4. Lysine-vasopressin Resin Cleavage at 40 °C for Two Hours (PPP3) 
(Scheme 1) 
Under this cleavage condition, benzyl (for cysteine protection), benzhydryl (for 
glutamine protection) and 1-tetralinyl (for asparagine protection) groups were 
completely removed. A large quantity of cyclic lysine-vasopressin was formed. 
The peak at m/z 1056.5 is cyclic lysine-vasopressin, with all protecting groups 
removed and the free mercapto groups oxidised. Comparing the three reaction 
conditions, the one done at 40 °C for two hours gave the best results with the target 
peptide formed in good yield. 
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 In cases where benzyl and benzhydryl are resistant to cleavage, incorporating 
electron-donating group(s) on the aromatic ring(s) will make their removal more 
facile.17 Electron-donating group(s) on the aromatic ring of 1-tetralinyl group will have 
the same effect. This is more enhanced if the electron-donating group is on position 6 
or 8 of the 1-tetralinyl group. 
 
 
Scheme 1 Synthetic scheme for the one-pot cleavage, deprotection and disulphide 
bond formation of lysine-vasopressin. 
 
 Amino acid analysis of the peptide showed that a substantial amount of tyrosine 
residue was destroyed during hydrolysis at 160–170 °C for three hours. This could 
have been due to the elevated temperature employed during automated hydrolysis. 




These studies have demonstrated the usefulness of 1-tetralinyl as a protecting group 
for the asparagine side-chain in Boc solid-phase peptide synthesis. The results 
obtained show that lysine-vasopressin, synthesised on a solid support, can be 
successfully deprotected and cleaved from the resin with consecutive disulphide 
bond formation in a one-pot reaction with thioanisole–1,2-ethanedithiol–TFA–TFMSA 
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